Cannabidiol for the Treatment of Neonatal Hypoxic-Ischemic Brain Injury
Each year, more than two million babies die or evolve to permanent invalidating sequelae worldwide because of Hypoxic-Ischemic Brain Injury (HIBI). There is no current treatment for that condition except for therapeutic hypothermia, which benefits only a select group of newborns. Preclinical studies...
Saved in:
Main Authors: | José Martínez-Orgado (Author), María Villa (Author), Aarón del Pozo (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of 5HT1A Receptors in the Neuroprotective and Behavioral Effects of Cannabidiol in Hypoxic-Ischemic Newborn Piglets
by: Lorena Barata, et al.
Published: (2022) -
Neurotoxicity of Unconjugated Bilirubin in Neonatal Hypoxic-Ischemic Brain Injury in vitro
by: Carlo Dani, et al.
Published: (2021) -
Diastolic Dysfunction in Neonates With Hypoxic-Ischemic Encephalopathy During Therapeutic Hypothermia: A Tissue Doppler Study
by: Maria Jose Rodriguez, et al.
Published: (2022) -
Effects of carnosine and hypothermia combination therapy on hypoxic-ischemic brain injury in neonatal rats
by: Jun Chul Byun, et al.
Published: (2021) -
Human Neural Stem Cells: Translational Research for Neonatal Hypoxic-Ischemic Brain Injury
by: Jeong Eun Shin, et al.
Published: (2019)